- Una Martin, senior lecturer in clinical pharmacology (u.martin@bham.ac.uk)1,
- Jamie J Coleman, specialist registrar in clinical pharmacology1
- 1 Department of Clinical Pharmacology, Division of Medical Sciences, University of Birmingham, Birmingham B15 2TH
- Correspondence to: U Martin
- Accepted 18 September 2006
We present two typical cases seen in a hospital hypertension clinic that illustrate the role of measurement of electrolytes and renal function in patients treated with angiotensin inhibitors (angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor antagonists) or potassium sparing diuretics. Both cases highlight the need to identify patients at increased risk of developing difficulties when taking such antihypertensive drugs and the need to target increased monitoring in at-risk patients.
Case 1
A 64 year old woman was referred to a hypertension clinic with a blood pressure of 180/110 mm Hg. Her biochemical profile was normal (serum creatinine concentration 102 µmol/l, urea 6.4 mmol/l, potassium 4.2 mmol/l, sodium 139 mmol/l). Treatment started with amlodipine 5 mg, and when she was reviewed, six weeks later, her blood pressure was 165/95 mm Hg. Perindopril 4 mg was added, and one week later her blood pressure was 144/70 mm Hg. However, her renal function showed some deterioration, with slight rises in serum creatinine concentration (110 µmol/l) and urea concentration (9.3 mmol/l). A month later the patient's blood pressure control remained good (140/70 mm Hg), but there was further deterioration in renal function (creatinine of 143 µmol/l, urea 10.4 mmol/l). A further month later, she was normotensive (139/71 mm Hg) with no further change in renal function (creatinine 143 µmol/l, urea 11 mmol/l).
In view of the deterioration in her renal function, she was investigated with a renal ultrasound scan followed by enhanced renal magnetic resonance angiogram. A short tight stenosis of the left renal artery was diagnosed. A nuclear medicine renal scan showed that …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
The decline in the breast cancer incidence is 1.2% and it is not significant.
Published 10 February 2012
'twas ever thus
Published 10 February 2012
The value of historic human remains
Published 10 February 2012
In Praise of British Literature
Published 10 February 2012
Is real shared decision making possible?
Published 10 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (7 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012
Search for evidence goes on (5 responses)
Published 17 Jan 2012